Avita Medical, Inc. (RCEL)
Last updated: 2026-10-21 16:12:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Avita Medical, Inc. (RCEL) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $14.88, with a market capitalization of $406.38M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.22 to $15.25. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$406.38M | |
$13.95 | |
$30.78 | |
$3.22 | |
$13.80 | |
277.44K | |
445.05K | |
-- | |
$15.25 | |
$3.22 | |
-- | |
-- |
Avita Medical, Inc. (RCEL) Stock Price Today
Avita Medical, Inc. (RCEL) is currently trading at $14.88 as of 2026-10-21 16:11:00, up 7.86% ($1.08) from the previous close of $13.80
During today's regular trading session, RCEL has traded between $3.22 and $30.78, with a trading volume of 277.44K shares. The current price is near the middle of today's range.
Avita Medical, Inc. (RCEL) 7-Day Stock Price Change
Over the past seven days, Avita Medical, Inc. (RCEL) moved from $13.37 to $14.88, representing a gain of 11.32% ($1.51).
The stock traded between $12.70 and $15.25 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 362.79 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
RCEL 52-Week Price Position
Position in Range: 97.0%
RCEL is currently trading at $14.88, placing it 97.0% of the way from its 52-week low of $3.22 to its 52-week high of $15.25. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Avita Medical, Inc. (RCEL)?
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
Avita Medical, Inc. Information
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 226 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Avita Medical, Inc. (RCEL) Stock on MEXC
Eligible investors can buy real shares of Avita Medical, Inc. (RCEL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Avita Medical, Inc. (RCEL) stock price today?
2.Is RCEL stock going up or down today?
3.What is RCEL pre-market price?
4.What is RCEL after-hours price?
5.Is RCEL stock trading now?
6.Where does RCEL sit relative to its 52-week high and low?
7.What sector is Avita Medical, Inc. in?
8.What is Avita Medical, Inc.'s market capitalization and where is it listed?
9.How is RCEL valued in terms of P/E ratio and EPS?
10.Does Avita Medical, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
RCEL Stock Calculator
Estimate the value between RCEL shares and USD.
RCEL Shares to USD
1.00 RCEL shares = 14.884 USD
Calculations are estimates based on the latest available price and are for reference only.


